[ORGANIZATION]
Merck & Co., Inc.
Featured in 12 tracked stories · first seen
Situations
Global EV market shifts and infrastructure challenges
42 clusters · 320 sources · last updated
Latest: Tesla beats third-quarter delivery estimates
By early October 2026, the global electric vehicle (EV) market has reached a significant milestone, with battery-electric vehicles (BEVs) accounting for approximately 20% of all new car registrations in August. When incl
Moderna and Merck melanoma vaccine clinical trials
16 clusters · 450 sources · last updated
Latest: Moderna expands cancer therapy ties and benefits from vaccine program news
Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon
AI-driven drug discovery and regulatory integration
17 clusters · 53 sources · last updated
Latest: Biopharmaceutical leaders call for European investment and AI oversight
By late September 2026, the pharmaceutical industry has transitioned from pilot programs to full-scale execution, focusing on integrating AI with real-time experimental data to create a ‘data closed loop’. Major partners
Also covered in
-
Merck secures $2.13B cancer drug license from SciBrunch
[BUSINESS] · 5 sources ·
-
Manufacturing and pharmaceutical stocks see high trading volumes
[BUSINESS] · 2 sources ·